PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Phenotype | C0007114|skin cancer |
| Sentences | 4 |
| PubMedID- 22241900 | The influence of anti-tnf therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the british society for rheumatology biologics register. |
| PubMedID- 23138614 | Concern has been raised about an increased risk of lymphoma and skin cancers in patients with rheumatoid arthritis due to administration of anti-tnf-alpha drugs. |
| PubMedID- 22382344 | Objective: to assess the risk of total malignancy and nonmelanoma skin cancers (nmsc) in patients with rheumatoid arthritis (ra) receiving certolizumab and golimumab through a metaanalysis of data from randomized control trials (rct). |
| PubMedID- 23549038 | We did not feel that this was appropriate in our study because a previous study of hospitalised patients with rheumatic diseases in scotland suggested even more atypical patterns of cancer risk among patients with osteoarthritis: sirs for all cancers (excluding non-melanoma skin cancer) in patients with rheumatoid arthritis were 1.11 (95% ci: 1.03–1.21) in male patients and 0.96 (95% ci: 0.90–1.01) in female patients; and in patients with osteoarthritis 0.85 (95% ci: 0.81–0.88) in male patients and 0.83 (95% ci: 0.80–0.86) in female patients (thomas et al, 2000). |
Page: 1